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summARy – Although collecting duct carcinoma is a subtype of renal cell carcinoma, several 
studies implicate association with urothelial carcinoma. The coexistence of collecting duct carcinoma 
and another renal neoplasm is rare. endemic nephropathy is a renal disease causing chronic renal 
failure. it is highly associated with urothelial neoplasm and occurs in endemic villages in Bosnia, 
Croatia, Bulgaria, Romania and serbia. Recent studies have confirmed the important role of exposure 
to aristolochic acid as an etiologic factor. we present three cases of collecting duct carcinoma with 
literature overview. in one case, we describe collecting duct carcinoma with metachronous urothelial 
carcinoma of the pyelon and urinary bladder in an endemic nephropathy patient. to our knowledge, 
this is the first case report describing this coexistence. Certain similarities between collecting duct 
carcinoma and urothelial carcinoma were found, e.g., higher incidence in female compared to male, 
higher mean age, and multifocal and multicentric occurrence of the tumor. our observations support 
the hypothesis that collecting duct carcinoma and urothelial carcinoma could be connected.
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Introduction
Collecting duct carcinoma (CdC) or Bellini duct 
carcinoma is a rare epithelial neoplasm of the kidney 
that accounts for 0.4% to 2.6% of all renal neoplasms1. 
These tumors behave in an aggressive manner with 
metastatic spread in one-third of patients at the time 
of diagnosis2,3. it predominantly occurs in younger 
male patients (mean age at diagnosis 43 years, male to 
female ratio (m/F) 2:1)4. endemic nephropathy (en) 
is a renal disease affecting inhabitants of rural areas in 
Bosnia, Croatia, Bulgaria, Romania and serbia. it 
causes chronic renal failure and has strong association 
with the high incidence of urothelial carcinoma of the 
upper urinary system (uC)5. Recent studies confirmed 




A 69-year-old woman from an endemic village 
presented with right renal colic and massive hematu-
ria. medical history revealed previous nephroureterec-
tomy of the left kidney due to invasive uC of the renal 
pelvis (pt3, g2), consistent with en. on ultrasound 
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(us) and computer tomography (Ct) scan, a tumor 
mass measuring 85x65x55 mm was found in the supe-
rior part of the contralateral right kidney. The patient 
underwent radical nephroureterectomy. histologically, 
the tumor was composed of small tubules with highly 
atypical cells and marked desmoplastic stroma. immu-
nohistochemical analysis with CK7, CK34ße12, 
Cd10 and vimentin confirmed the diagnosis of CdC 
(pt3, g2) (Fig. 1 A, B, C). postoperatively, the patient 
was referred to hemodialysis and discharged home in 
good condition. After eight months, she was readmit-
ted to the hospital due to severe hematuria. Cystosco-
py revealed a tumor of the urinary bladder. salvage 
cystectomy was performed. histopathologic analysis 
showed uC (pt1, g2, high grade according to the 
world health organization (who) classification 
from 2004). The patient died 11 months after the ini-
tial diagnosis due to malignant disease.
Case 2
A 66-year-old male was admitted to the hospital 
due to lower urinary tract symptoms. Routine us de-
scribed suspicious hypoechogenic zones in the right 
kidney, and Ct confirmed a tumor mass measuring 
44x43 mm. Radical nephrectomy was performed. his-
topathologic examination with immunohistochemis-
try diagnosed CdC (pt3a, g4). After 10 days, the 
patient was discharged in a satisfactory condition. due 
to poor general state, chemotherapy and radiotherapy 
were not indicated. eight months after the initial di-
agnosis, the patient’s condition deteriorated (with 
malaise and loss of weight) and the patient died.
Case 3
A female patient aged 61 suffering from hematuria 
and right lumbar pain was admitted. us showed a right 
kidney tumor. Ct detected a soft tumorous mass mea-
suring 40x35x30 mm in the lower and middle group of 
calices. Radical nephrectomy of the right kidney was 
performed. imunohistologically, the tumor was diag-
nosed as Bellini duct carcinoma with positive regional 
lymph nodes (pt3n1, g3). six days after surgery, the 
patient was discharged in good condition. Chemother-
apy was administered (m-vAC protocol and sorafenib). 
The patient developed lung metastases after 10 months. 
liver and bone metastases were found in additional 6 
months. The patient died 18 months after the initial di-
agnosis due to primary disease.
All procedures performed in the studies involving 
human participants were in accordance with ethical 
standards of the institutional and/or national research 
committee and with the 1964 helsinki declaration 
and its later amendments or comparable ethical stan-
dards. An informed consent was obtained from all pa-
tients included in the study.
Fig. 1. Histologically, the tumor was composed of small 
tubules with highly atypical cells and marked desmoplastic 
stroma (hemalaun/eosin x100) (A); 
immunohistochemically positive CK7x100 (B);  
and CK34ßE12x200 (C).
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Discussion
Collecting duct carcinoma is a rare neoplasm with 
1% incidence of all renal tumors7. The coexistence with 
another renal neoplasm has been rarely described, usu-
ally with other subtypes of renal cell carcinoma (RCC) 
and uC8. According to the who, CdC is a subtype 
of RCC, although some authors implicate association 
and similarities with uC9. The possible association of 
CdC and uC may reflect their common embryologic 
origin in wolf ’s duct10. our observations suggest some 
similarities between CdC and uC.
we analyzed all nephrectomy cases treated for re-
nal and ureteral tumor at the department of urology 
in the endemic nephropathy region during the 2008-
2010 period. during the study period, 84 cases were 
diagnosed as renal or ureteral tumor (m/F=1:1.27, 
mean age 68.2). RCC was diagnosed in 29 cases (m/
F=1.63:1, mean age 63.9), uC in 52 cases (m/
F=1:1.88, mean age 74.3), and CdC in 3 cases (m/
F=1:2, mean age 66.6). The incidence of CdC in our 
department was 3.57% of all renal tumors including 
upper urinary tract (pyelon, ureter), which was higher 
than expected concerning literature data10.
in Case 1, en presenting with uC of the renal pel-
vis and urinary bladder occurred metachronously with 
CdC. to our knowledge, this is the first case report of 
this rare coexistence in the english literature. nowa-
days, en and uC are considered to be different clini-
cal presentations of one disease that is influenced by 
exposure to aristolochic acid6. Following metabolic 
activation, aristolochic acid reacts with genomic dnA 
to form aristolactam-dnA adducts that generate a 
unique A:t to t:A transversions in the nontranscribed 
tp53 mutational spectrum. Therefore, these, other-
wise rare mutations are a biomarker of exposure to 
aristolochic acid11. upper uC is present in 50% of en 
cases, while they account for only 5% of all urinary 
tract cancers worldwide5. specific uC mortality in the 
en region compared to Croatia is 55 times higher 
(with female predominance)12. patients from endemic 
region with uC tend to have impaired kidney func-
tion. According to the modified who criteria, en is 
defined by living in endemic region for more than 15 
years, impaired kidney and anemia with exclusion of 
other causes of chronic kidney disease. typical renal 
histopathology in early stages of en shows extensive 
cortical tubular atrophy and dense interstitial fibrosis 
with gradient and little inflammation, but due to sec-
ondary changes, it is frequently insufficient for making 
the diagnosis of en in older population. our first case 
of a patient from a Bosnian endemic village met the 
en criteria; according to the epidemiologic survey, the 
patient had been exposed to aristolochic acid, and 
apart from Bellini duct carcinoma, had uC of the py-
elon and a severely reduced kidney function (egFR 17 
ml/min). histopathologic examination also revealed 
chronic pyelonephritis with already advanced intersti-
tial fibrosis. tumor tp53 mutational spectrum, using 
p53 AmpliChip technology, demonstrated specific 
A:t to t:A transversions, which are the biomarker of 
exposure to aristolochic acid, and consequently en 
marker. Therefore, this is a unique case of two different 
rare conditions and urothelial tract tumors in the same 
patient.
our analysis confirmed that in the en region, uC 
occurs more frequently than RCC, with a female pre-
dominance and higher mean age at onset. it is also ob-
served that uC in en regions is more frequently bilat-
eral, multifocal and multicentric13. CdC from our en-
demic region shared some similarities with uC, e.g., 
higher incidence in female than male, higher mean 
age, and metachronous urothelial carcinoma of the py-
elon and urinary bladder in one patient. CdC might 
be distinct from conventional RCC but shares biologic 
features with uC, with consequent implications for its 
management9. Because of the close relationship be-
tween CdC and uC (a common embryologic origin 
that arises from the mesonephrons), CdC could also 
have similarities with uC from endemic region in risk 
factors and showing a higher incidence in endemic 
 region.
The understanding of the CdC is still insufficient. 
it is a disease with poor prognosis, survival and re-
sponse to target therapies3,14. The cases reported in this 
paper could contribute to deeper understanding of the 
rare CdC entity. Regarding this, our study supports 
the hypothesis that CdC and uC could be connected. 
Further larger studies on the possible connection to 
en are needed.
Conclusion
The coexistence of CdC with other renal neo-
plasms is rare. we report the first case of CdC coex-
isting with uC of the pyelon and urinary bladder in an 
en patient. Recently, aristolochic acid was confirmed 
as an etiologic factor for en. on the other hand, the 
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understanding of CdC is still insufficient. This report 
presents an intriguing connection between CdC and 
uC of the upper urinary tract. The cases reported in 
this paper could contribute to better understanding of 
the rare CdC entity.
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sažetak
KARCinom sABiRnih KAnAliĆA i endemsKA neFRopAtiJA  
– pRiKAZi sluČAJA i pRegled liteRAtuRe
M. Knežević, K. Tomić, D. Dittrich, I. Vuković Lela, B. Ružić, B. Spajić, K. Karlović i G. Štimac
iako je karcinom sabirnih kanalića podvrsta karcinoma bubrežnih stanica, određena istraživanja ukazuju na povezanost 
ovog entiteta s karcinomom prijelaznog epitela. istodobna pojava karcinoma sabirnih kanalića i drugih bubrežnih neoplazma 
je rijetka. endemska nefropatija je bubrežna bolest koja dovodi do kroničnog bubrežnog zatajenja. vrlo je povezana s urotel-
nim tumorima i javlja se u endemskim selima u Bosni, hrvatskoj, Bugarskoj, Rumunjskoj i srbiji. nedavna istraživanja po-
tvrdila su značajnu ulogu izloženosti aristolohičnoj kiselini kao etiološkom čimbeniku. predstavljamo tri slučaja karcinoma 
sabirnih kanalića s pregledom literature. u jednom slučaju opisujemo karcinom sabirnih kanalića s metakronom pojavom 
urotelnog karcinoma pijelona te mokraćnog mjehura u bolesnika s potvrđenom endemskom nefropatijom. prema našim 
 saznanjima ovo je prvi slučaj koji opisuje ovakvu koegzistenciju. pronađene su određene sličnosti između karcinoma sabirnih 
kanalića i karcinoma prijelaznog epitela, a to su veća učestalost u ženskoj populaciji, viša prosječna dob, multifokalna i mul-
ticentrična pojava tumora. naša zapažanja podupiru hipotezu o mogućoj povezanosti karcinoma sabirnih kanalića i karcino-
ma prijelaznog epitela.
Ključne riječi: Karcinom sabirnih kanalića; Karcinom Bellinijeva kanalića; Endemska nefropatija; Bubrežna novotvorina; 
Bubrežno zatajenje; Karcinom urotela
